You are here

  • Home
  • Archive
  • Volume 76, Issue 2
  • Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?

Citation Tools

Article menu

Download PDFPDF

Electronic pages
Correspondence
Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Nocturne G, Seror R, Mariette X
Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?
Annals of the Rheumatic Diseases 2017;76:e3.